 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Sigal Charles Elliott
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-05-16 Purchase | 2016-05-18 7:34 pm | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 45,000 | $1.5267 | $68,700 | 299,100 (Indirect Direct) | View |
| 2016-05-19 Purchase | 2016-05-19 4:47 pm | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 15,000 | $1.56 | $23,400 | 314,100 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-08-11 Option Award | 2016-08-12 4:30 pm | 2017-08-11 2026-08-11 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 184,562 | $0 | 184,562 (Direct) | View |
| 2017-07-03 Option Award | 2017-07-03 5:01 pm | 2018-07-03 2027-07-03 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 220,788 | $0 | 220,788 (Direct) | View |
| 2018-04-23 Conversion | 2018-04-23 4:15 pm | N/A N/A | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 45,453 | $0 | 45,453 (Indirect) | View |
| 2018-04-23 Conversion | 2018-04-23 4:15 pm | N/A N/A | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 100,000 | $0 | 0 (Indirect) | View |
| 2018-06-22 Option Award | 2018-06-26 5:00 pm | 2019-06-22 2028-06-22 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 154,809 | $0 | 154,809 (Direct) | View |
| 2018-07-02 Option Award | 2018-07-05 4:06 pm | N/A 2028-07-02 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 8,882 | $0 | 8,882 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-06 4:46 pm | N/A 2029-06-05 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 12,100 | $0 | 12,100 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 5:19 pm | N/A 2029-07-01 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 5,696 | $0 | 5,696 (Direct) | View |
| 2019-07-02 Option Award | 2019-07-03 5:00 pm | 2020-07-02 2029-07-02 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 234,407 | $0 | 234,407 (Direct) | View |
| 2019-10-01 Option Award | 2019-10-03 4:33 pm | N/A 2029-10-01 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 13,572 | $0 | 13,572 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-01 5:07 pm | 2021-07-01 2030-07-02 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 184,258 | $0 | 184,258 (Direct) | View |
| 2020-07-10 Option Award | 2020-07-14 8:22 pm | N/A 2030-07-10 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 57,777 | $0 | 57,777 (Direct) | View |
| 2020-07-10 Option Award | 2020-10-13 7:16 pm | N/A 2030-07-09 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 28,394 | $0 | 28,394 (Direct) | View |